M
Michele Malaguarnera
Researcher at University of Catania
Publications - 127
Citations - 4645
Michele Malaguarnera is an academic researcher from University of Catania. The author has contributed to research in topics: Cancer & Hepatitis C. The author has an hindex of 31, co-authored 123 publications receiving 3846 citations. Previous affiliations of Michele Malaguarnera include University of Valencia.
Papers
More filters
Journal ArticleDOI
Vitamin D3: a helpful immuno-modulator
TL;DR: This review reports the new developments with specific reference to the metabolic and signalling mechanisms associated with the complex immune‐regulatory effects of vitamin D3 on immune cells.
Journal ArticleDOI
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Michele Malaguarnera,Marco Vacante,Tijana Antic,Maria Giordano,Giuseppe Chisari,Rosaria Acquaviva,Silvana Mastrojeni,Giulia Malaguarnera,Antonio Mistretta,Giovanni Li Volti,Fabio Galvano +10 more
TL;DR: Bifidobacterium longum with Fos and lifestyle modification, when compared to lifestyle modification alone, significantly reduces TNF-α, CRP, serum AST levels, HOMA-IR, serum endotoxin, steatosis, and the NASH activity index.
Journal ArticleDOI
Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms
Giuseppe Grosso,Fabio Galvano,Stefano Marventano,Michele Malaguarnera,Claudio Bucolo,Filippo Drago,Filippo Caraci +6 more
TL;DR: Tertiary prevention with omega-3 PUFA supplement in depressed patients has reached greater effectiveness during the last recent years, although definitive statements on their use in depression therapy cannot be yet freely asserted.
Journal ArticleDOI
L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial.
Mariano Malaguarnera,Maria Pia Gargante,Cristina Russo,Tijana Antic,Marco Vacante,Michele Malaguarnera,Teresio Avitabile,Giovanni Li Volti,Fabio Galvano +8 more
TL;DR: L-carnitine supplementation to diet is useful for reducing TNF-α and CRP, and for improving liver function, glucose plasma level, lipid profile, HOMA-IR, and histological manifestations of NASH.
Journal ArticleDOI
Potential role of probiotics on colorectal cancer prevention
Mario Uccello,Giulia Malaguarnera,Francesco Basile,Velia D'Agata,Michele Malaguarnera,Gaetano Bertino,Marco Vacante,Filippo Drago,Antonio Biondi +8 more
TL;DR: Several mechanisms could explain the preventive action of probiotics against colorectal cancer onset: alteration of the intestinal microflora; inactivation of cancerogenic compounds; competition with putrefactive and pathogenic microbiota; improvement of the host’s immune response; and inhibition of tyrosine kinase signaling pathways.